|
1
|
World Health Organization. WHO fact sheet
No. 297. World Health Organization; Geneva: 2006
|
|
2
|
Garzon R, Fabbri M, Cimmino A, Calin GA
and Croce CM: MicroRNA expression and function in cancer. Trends
Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gregory RI, Chendrimada TP, Cooch N and
Shiekhattar R: Human RISC couples microRNA biogenesis and
post-transcriptional gene silencing. Cell. 123:631–640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: The implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jay C, Nemunaitis J, Chen P, Fulgham P and
Tong AW: miRNA profiling for diagnosis and prognosis of human
cancer. DNA Cell Biol. 26:293–300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan D: The hippo signaling pathway in
development and cancer. Dev Cell. 19:491–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yabuta N, Okada N, Ito A, Hosomi T,
Nishihara S, Sasayama Y, Fujimori A, Okuzaki D, Zhao H, Ikawa M, et
al: Lats2 is an essential mitotic regulator required for the
coordination of cell division. J Biol Chem. 282:19259–19271. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Pei J, Xia H, Ke H, Wang H and Tao
W: Lats2, a putative tumor suppressor, inhibits G1/S transition.
Oncogene. 22:4398–4405. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in Drosophila and
mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oka T, Mazack V and Sudol M: Mst2 and Lats
kinases regulate apoptotic function of Yes kinase-associated
protein (YAP). J Biol Chem. 283:27534–27546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia Y and Gao Y: MicroRNA-181b promotes
ovarian cancer cell growth and invasion by targeting LATS2. Biochem
Biophys Res Commun. 447:446–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C,
Li H, O'Malley YQ, Askeland RW, Sugg S, Liu M, et al: MiR-93
enhances angiogenesis and metastasis by targeting LATS2. Cell
Cycle. 11:4352–4365. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho WJ, Shin JM, Kim JS, Lee MR, Hong KS,
Lee JH, Koo KH, Park JW and Kim KS: miR-372 regulates cell cycle
and apoptosis of ags human gastric cancer cell line through direct
regulation of LATS2. Mol Cells. 28:521–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin CW, Chang YL, Chang YC, Lin JC, Chen
CC, Pan SH, Wu CT, Chen HY, Yang SC, Hong TM, et al: MicroRNA-135b
promotes lung cancer metastasis by regulating multiple targets in
the Hippo pathway and LZTS1. Nat Commun. 4:18772013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He Y, Wang J, Wang J, Yung VY, Hsu E, Li
A, Kang Q, Ma J, Han Q, Jin P, et al: MicroRNA-135b regulates
apoptosis and chemoresistance in colorectal cancer by targeting
large tumor suppressor kinase 2. Am J Cancer Res. 5:1382–1395.
2015.PubMed/NCBI
|
|
19
|
Li Y, Xu D, Bao C, Zhang Y, Chen D, Zhao
F, Ding J, Liang L, Wang Q, Liu L, et al: MicroRNA-135b, a HSF1
target, promotes tumor invasion and metastasis by regulating RECK
and EVI5 in hepatocellular carcinoma. Oncotarget. 6:2421–2433.
2015. View Article : Google Scholar :
|
|
20
|
Zhang L, Sun ZJ, Bian Y and Kulkarni AB:
MicroRNA-135b acts as a tumor promoter by targeting the
hypoxia-inducible factor pathway in genetically defined mouse model
of head and neck squamous cell carcinoma. Cancer Lett. 331:230–238.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagel R, le Sage C, Diosdado B, van der
Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R:
Regulation of the adenomatous polyposis coli gene by the miR-135
family in colorectal cancer. Cancer Res. 68:5795–5802. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valeri N, Braconi C, Gasparini P, Murgia
C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat
F, et al: MicroRNA-135b promotes cancer progression by acting as a
downstream effector of oncogenic pathways in colon cancer. Cancer
Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu W, Wang Z, Yang P, Yang J, Liang J,
Chen Y, Wang H, Wei G, Ye S and Zhou Y: MicroRNA-135b regulates
metastasis suppressor 1 expression and promotes migration and
invasion in colorectal cancer. Mol Cell Biochem. 388:249–259. 2014.
View Article : Google Scholar
|
|
24
|
He YQ, Sheng JQ, Ling XL, Fu L, Jin P, Yen
L and Rao J: Estradiol regulates miR-135b and mismatch repair gene
expressions via estrogen receptor-β in colorectal cells. Exp Mol
Med. 44:723–732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao S, Yang Z, Lv R, Zhao J, Wu M, Liao Y
and Liu Q: miR-135b contributes to the radioresistance by targeting
GSK3β in human glioblastoma multiforme cells. PLoS One.
9:e1088102014. View Article : Google Scholar
|
|
26
|
Pei H, Jin Z, Chen S, Sun X, Yu J and Guo
W: MiR-135b promotes proliferation and invasion of osteosarcoma
cells via targeting FOXO1. Mol Cell Biochem. 400:245–252. 2015.
View Article : Google Scholar
|
|
27
|
Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung
WW, Law WT, Yau TO, Chan FK, Sung JJ, et al: Identification of
microRNA-135b in stool as a potential noninvasive biomarker for
colorectal cancer and adenoma. Clin Cancer Res. 20:2994–3002. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo Q, Li X, Li J, Kong X, Zhang J, Chen
L, Huang Y and Fang L: MiR-15a is underexpressed and inhibits the
cell cycle by targeting CCNE1 in breast cancer. Int J Oncol.
43:1212–1218. 2013.PubMed/NCBI
|
|
30
|
Li J, Kong X, Zhang J, Luo Q, Li X and
Fang L: Correction: MiRNA-26b inhibits proliferation by targeting
PTGS2 in breast cancer. Cancer Cell Int. 13:172013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Justice RW, Zilian O, Woods DF, Noll M and
Bryant PJ: The Drosophila tumor suppressor gene warts encodes a
homolog of human myotonic dystrophy kinase and is required for the
control of cell shape and proliferation. Genes Dev. 9:534–546.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dupont S, Morsut L, Aragona M, Enzo E,
Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M,
Bicciato S, et al: Role of YAP/TAZ in mechanotransduction. Nature.
474:179–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mohseni M, Sun J, Lau A, Curtis S,
Goldsmith J, Fox VL, Wei C, Frazier M, Samson O, Wong KK, et al: A
genetic screen identifies an LKB1-MARK signalling axis controlling
the Hippo-YAP pathway. Nat Cell Biol. 16:108–117. 2014. View Article : Google Scholar :
|
|
35
|
Callus BA, Verhagen AM and Vaux DL:
Association of mammalian sterile twenty kinases, Mst1 and Mst2,
with hSalvador via C-terminal coiled-coil domains, leads to its
stabilization and phosphorylation. FEBS J. 273:4264–4276. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chan EH, Nousiainen M, Chalamalasetty RB,
Schäfer A, Nigg EA and Silljé HH: The Ste20-like kinase Mst2
activates the human large tumor suppressor kinase Lats1. Oncogene.
24:2076–2086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Praskova M, Xia F and Avruch J:
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell
proliferation. Curr Biol. 18:311–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hao Y, Chun A, Cheung K, Rashidi B and
Yang X: Tumor suppressor LATS1 is a negative regulator of oncogene
YAP. J Biol Chem. 283:5496–5509. 2008. View Article : Google Scholar
|
|
39
|
Oka T, Mazack V and Sudol M: Mst2 and Lats
kinases regulate apoptotic function of Yes kinase-associated
protein (YAP). J Biol Chem. 283:27534–27546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lei QY, Zhang H, Zhao B, Zha ZY, Bai F,
Pei XH, Zhao S, Xiong Y and Guan KL: TAZ promotes cell
proliferation and epithelial-mesenchymal transition and is
inhibited by the hippo pathway. Mol Cell Biol. 28:2426–2436. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kanai F, Marignani PA, Sarbassova D, Yagi
R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley
LC, et al: TAZ: A novel transcriptional co-activator regulated by
interactions with 14-3-3 and PDZ domain proteins. EMBO J.
19:6778–6791. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang H, Liu CY, Zha ZY, Zhao B, Yao J,
Zhao S, Xiong Y, Lei QY and Guan KL: TEAD transcription factors
mediate the function of TAZ in cell growth and
epithelial-mesenchymal transition. J Biol Chem. 284:13355–13362.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Varelas X, Sakuma R, Samavarchi-Tehrani P,
Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW and Wrana JL:
TAZ controls Smad nucleocytoplasmic shuttling and regulates human
embryonic stem-cell self-renewal. Nat Cell Biol. 10:837–848. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Strano S, Munarriz E, Rossi M, Castagnoli
L, Shaul Y, Sacchi A, Oren M, Sudol M, Cesareni G and Blandino G:
Physical interaction with Yes-associated protein enhances p73
transcriptional activity. J Biol Chem. 276:15164–15173. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang X, Su L and Ou Q: Yes-associated
protein promotes tumour development in luminal epithelial derived
breast cancer. Eur J Cancer. 48:1227–1234. 2012. View Article : Google Scholar
|
